RWA Wealth Partners LLC Grows Holdings in CME Group Inc. (NASDAQ:CME)

RWA Wealth Partners LLC grew its holdings in shares of CME Group Inc. (NASDAQ:CME) by 1,067.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 16,996 shares of the financial services provider’s stock after buying an additional 15,540 shares during the quarter. RWA Wealth Partners LLC’s holdings in CME Group were worth $3,579,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in CME. MCF Advisors LLC raised its position in shares of CME Group by 26.7% during the 4th quarter. MCF Advisors LLC now owns 285 shares of the financial services provider’s stock valued at $61,000 after acquiring an additional 60 shares in the last quarter. Commerzbank Aktiengesellschaft FI increased its position in CME Group by 2.3% in the fourth quarter. Commerzbank Aktiengesellschaft FI now owns 40,904 shares of the financial services provider’s stock worth $8,614,000 after buying an additional 904 shares during the period. CWM LLC grew its stake in shares of CME Group by 12.2% in the fourth quarter. CWM LLC now owns 21,289 shares of the financial services provider’s stock worth $4,483,000 after purchasing an additional 2,312 shares in the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd grew its stake in shares of CME Group by 2.3% in the fourth quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 42,413 shares of the financial services provider’s stock worth $8,932,000 after purchasing an additional 946 shares in the last quarter. Finally, Signaturefd LLC grew its stake in shares of CME Group by 7.8% in the fourth quarter. Signaturefd LLC now owns 5,394 shares of the financial services provider’s stock worth $1,136,000 after purchasing an additional 392 shares in the last quarter. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

CME Group Stock Up 1.1 %

CME opened at $215.48 on Tuesday. CME Group Inc. has a fifty-two week low of $175.73 and a fifty-two week high of $223.80. The business has a 50-day moving average of $214.59 and a 200-day moving average of $211.89. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The company has a market capitalization of $77.57 billion, a PE ratio of 24.29, a price-to-earnings-growth ratio of 6.04 and a beta of 0.49.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, February 14th. The financial services provider reported $2.37 earnings per share for the quarter, topping analysts’ consensus estimates of $2.27 by $0.10. CME Group had a return on equity of 12.32% and a net margin of 57.83%. The company had revenue of $1.44 billion during the quarter, compared to the consensus estimate of $1.43 billion. During the same period last year, the business earned $1.92 EPS. The business’s quarterly revenue was up 19.2% on a year-over-year basis. Equities research analysts forecast that CME Group Inc. will post 9.57 EPS for the current fiscal year.

CME Group Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 26th. Stockholders of record on Friday, March 8th were paid a dividend of $1.15 per share. The ex-dividend date of this dividend was Thursday, March 7th. This is an increase from CME Group’s previous quarterly dividend of $1.10. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.13%. CME Group’s dividend payout ratio (DPR) is 51.86%.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on CME shares. Keefe, Bruyette & Woods reissued a “market perform” rating and issued a $229.00 price target on shares of CME Group in a research note on Wednesday, April 3rd. Morgan Stanley increased their price target on CME Group from $222.00 to $225.00 and gave the stock an “equal weight” rating in a research note on Tuesday, April 9th. Argus increased their price target on CME Group from $225.00 to $245.00 and gave the stock a “buy” rating in a research note on Wednesday, March 6th. The Goldman Sachs Group cut CME Group from a “neutral” rating to a “sell” rating and set a $195.00 target price for the company. in a research note on Wednesday, January 3rd. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and set a $210.00 target price (down previously from $235.00) on shares of CME Group in a research note on Friday, April 5th. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $215.70.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.